SIA "PHARMAMAX"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 92 749 € (90% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2015–2025
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||
| Total current assets | 276 388 | 359 876 | 439 331 | 320 596 | 680 610 | 870 457 | 642 536 | 575 904 | 967 219 | 594 240 | 877 638 |
| Total non-current assets | 0 | 0 | 8092 | 11 400 | 7886 | 4254 | 351 | 2479 | 3340 | 326 853 | 772 442 |
| Total assets | 276 388 | 359 876 | 447 423 | 331 996 | 688 496 | 874 711 | 642 887 | 578 383 | 970 559 | 921 093 | 1 650 080 |
| Balance sheet — liabilities and equity | |||||||||||
| Current liabilities | 0 | 34 790 | 41 453 | 25 977 | 77 102 | 199 768 | 223 811 | 389 558 | 611 217 | 817 844 | 1 637 753 |
| Non-current liabilities | 696 | 0 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 696 | 34 790 | 41 453 | 25 977 | 77 102 | 199 781 | 223 811 | 389 558 | 611 217 | 817 844 | 1 637 753 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -24 308 | 49 394 | 80 884 | 6019 | 305 343 | 553 568 | 344 146 | 169 749 | 339 517 | 78 407 | 1827 |
| Total equity | 275 692 | 325 086 | 405 970 | 306 019 | 611 362 | 674 930 | 419 076 | 188 825 | 359 342 | 103 249 | 12 327 |
| Income statement | |||||||||||
| Sales revenue | 2215 | 449 415 | 1 588 219 | 2 623 130 | 2 749 028 | 3 720 583 | 3 282 579 | 2 521 925 | 5 070 928 | 6 714 748 | 6 133 681 |
| Operating profit | -24 308 | 53 656 | 95 627 | 6007 | 305 748 | 604 037 | 502 185 | 266 422 | 381 897 | 469 568 | 568 559 |
| EBITDA | -24 308 | — | — | — | — | — | — | — | — | — | — |
| Profit before income tax | -24 308 | 53 656 | 95 657 | 6143 | 305 859 | 604 037 | 502 521 | 269 749 | 381 897 | 516 068 | 568 559 |
| Profit for the reporting year | -24 308 | 49 394 | 80 884 | 6019 | 305 343 | 553 568 | 344 146 | 169 749 | 339 517 | 78 407 | 1827 |
| Labour costs | 9342 | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | 0 | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||
| Employees | 3 | 5 | 4 | 4 | 4 | 5 | 7 | 6 | 9 | 9 | 9 |
| Calculated dividend | — | 0 | 0 | 105 970 | 0 | 490 000 | 600 000 | 400 000 | 169 000 | 334 500 | 92 749 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: SIA "PHARMAMAX"
Overview
SIA "PHARMAMAX" (reg. no. 40103879002) is a limited liability company. The company was registered in 2015 and has been in the register for 11 years. Registered address: Rīga, Dēļu iela 4.
Financial results
Revenue in 2025 was 6 133 681 €, down 8,7% on the previous year (6 714 748 €). From 2015 to 2025, revenue grew by an average of 121% per year. Net profit for 2025 was 1827 € (0,0% of revenue). The company was profitable in 10 of the 11 published years. In 2025 the company had 9 employees. Revenue per employee was 681 520 €. At the end of 2025, total assets were 1 650 080 € and equity 12 327 € (0,7% of assets).
Management and owners
The company has one board member. According to the register, the company has 2 owners. The largest stake (52,4%) is held by a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.